Acthar Claimants Hit Skadden For Mallinckrodt Ch. 11 Role
Law360 (February 5, 2021, 8:42 PM EST) -- Class attorneys for alleged victims of Mallinckrodt PLC's Acthar Gel product asked a Delaware bankruptcy judge to hold a hearing on Skadden's role in the drug company's Chapter 11 in Delaware, pointing to allegedly undisclosed, potentially disqualifying conduct and conflicts of interest.
The late Thursday objection, which followed the same group's bid on Feb. 1 for the retention of a trustee to direct the case, cited Skadden Arps Slate Meagher & Flom LLP's purported failure to fully disclose in "ordinary course professional" declarations its prepetition work for Express Scripts, a Mallinckrodt co-defendant in multistate, prepetition fraud and antitrust litigation.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!